Back
Astria Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
23
ATXS
Astria Therapeutics
Last Price:
$9.51
Seasonality Move:
16.9%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXS is experiencing slight buying pressure.
Astria Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.52 | Buy |
| 20-day SMA: | 9.94 | Sell |
| 50-day SMA: | 10.59 | Sell |
| 200-day SMA: | 10.84 | Sell |
| 8-day EMA: | 9.6 | Sell |
| 20-day EMA: | 9.86 | Sell |
| 50-day EMA: | 10.34 | Sell |
| 200-day EMA: | 10.54 | Sell |
Astria Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 42.34 | Sell |
| Chaikin Money Flow: | 134673 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.5 - 10.26) | Sell |
| Bollinger Bands (100): | (10 - 11.84) | Sell |
Astria Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Astria Therapeutics Stock
Is Astria Therapeutics Stock a Buy?
-
Astria Therapeutics share price is 9.54 while ATXS 8-day simple moving average is 9.52, which is a Buy signal.
-
The stock price of ATXS is 9.54 while Astria Therapeutics 20-day SMA is 9.94, which makes it a Sell.
-
Astria Therapeutics 50-day simple moving average is 10.59 while ATXS share price is 9.54, making it a Sell technically.
-
ATXS stock price is 9.54 and Astria Therapeutics 200-day simple moving average is 10.84, creating a Sell signal.
ATXS Technical Analysis vs Fundamental Analysis
Sell
23
Astria Therapeutics (ATXS)
is a Sell
Is Astria Therapeutics a Buy or a Sell?
-
Astria Therapeutics stock is rated a SellThe current Astria Therapeutics [ATXS] share price is $9.54. The Score for ATXS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Astria Therapeutics Stock Info
Market Cap:
538.4M
Price in USD:
9.54
Share Volume:
314.2K
Astria Therapeutics 52-Week Range
52-Week High:
16.90
52-Week Low:
6.58
Sell
23
Astria Therapeutics (ATXS)
is a Sell
Astria Therapeutics Share Price Forecast
-
What is the Astria Therapeutics stock price today?The Astria Therapeutics stock price is 9.54 USD today.
-
Will ATXS stock go up or go down?Astria Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Astria Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Astria Therapeutics is overvalued.
Is Astria Therapeutics Stock a Buy?
-
Astria Therapeutics share price is 9.54 while ATXS 8-day exponential moving average is 9.60, which is a Sell signal.
-
The stock price of ATXS is 9.54 while Astria Therapeutics 20-day EMA is 9.86, which makes it a Sell.
-
Astria Therapeutics 50-day exponential moving average is 10.34 while ATXS share price is 9.54, making it a Sell technically.
-
ATXS stock price is 9.54 and Astria Therapeutics 200-day simple moving average is 10.54, creating a Sell signal.
Fundamental Analysis of Astria Therapeutics
Is Astria Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.10 per share.
Technical Analysis of Astria Therapeutics
Should I short Astria Therapeutics stock?
-
ATXS Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Astria Therapeutics is a Sell
-
Astria Therapeutics Relative Strength Index (RSI) is 42.34, which suggest Astria Therapeutics is oversold
-
The Bollinger Bands (25) for Astria Therapeutics is (9.5 - 10.26), which suggest Astria Therapeutics is a Sell
-
The Bollinger Bands (100) for Astria Therapeutics is (10 - 11.84), which suggest Astria Therapeutics is a Sell
* Astria Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.